Development of a highly sensitive in vitro phototoxicity assay using the SkinEthic reconstructed human epidermis

Cell Biology and Toxicology, 16(6):391-400

BERNARD FX., BARRAULT C., DEGUERCY A., DE WEVER B. and ROSDY M. (2000)

SkinEthic, 15 rue Hérold, 06000 Nice, France.
Bioalternatives, Gençay, France.

Abstract

The reconstituted human epidermis model SkinEthic was used to evaluate the phototoxicity of topically applied chemicals.
For comparison with published data, we first tested a library of 13 nonphototoxic (NPT) and phototoxic (PT) compounds, applied onto SkinEthic reconstituted human epidermal tissues, in a protocol as close as possible to the one described by Liebsch using another skin tissue model.
The results showed that, under these nonoptimized conditions, the SkinEthic model was already able to fully discriminate between known NPT and PT compounds. Furthermore, these epidermal tissues being highly resistant to UVA irradiation, it was possible to increase irradiation by (at least) 3-fold without decrease in tissue viability. In such conditions, the phototoxicity assay is much more sensitive, so that the model is expected to be of great interest for the detection not only of strong but also of weak phototoxic compounds.

© 2000 Kluwer Academic Publishers.

KEYWORDS: Phototoxicity; in vitro; Ultraviolet A; Reconstituted human epidermis; SkinEthicTM

Related posts

Check out Bioalternatives’ updates and experience new testing ideas

  • Bioassays, models and services
  • Posts and publications
  • Events

  • The legal basis for the processing is consent. Your e-mail address will only be communicated to the following recipients: the departments concerned and authorised by QIMA LIFE SCIENCE. This data is kept for as long as you are registered to the newsletter.

    You can access your data, rectify it, request its deletion or exercise your right to limit the processing of your data, withdraw your consent to the processing of your data at any time, oppose the processing of your data and you have a right to the portability of your data.

    Visit cnil.fr for more information on your rights.
    You can exercise all your rights using the following linkGestion des droits or by writing to dpo-qima@agencergpd.eu. If you feel, after contacting us, that your "Informatique et Libertés" rights are not being respected, you can submit a complaint to the CNIL.

  • The information collected on this form is recorded in a file used by QIMA Life Sciences to send you its newsletter.